Literature DB >> 8276289

Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma.

M A Killackey1, A R Davis.   

Abstract

Between 1984 and 1991, 199 patients underwent laparotomy for epithelial "ovarian" malignancy. In 29 cases (15%) normal-sized ovaries (< 4 cm in diameter) with minimal invasion by papillary serous carcinoma were found. This entity in the setting of peritoneal carcinomatosis has been previously described and is reported here as papillary serous cancer of the peritoneal surface (PSPS). The clinical, surgical, and pathologic features of PSPS are compared with a group of age-, grade-, and stage-matched cases with papillary serous ovarian carcinomas (PSOC). PSPS was also characterized by ascites (mean = 3036 cc), malignant washings (91%), and omental involvement with bulky infiltration and/or multiple tumor nodules (96%). Mean cytoreduction in the PSPS group was 65.5% compared to 79% in the PSOC group (P = 0.049). Patients received combination chemotherapy with platinum-based regimens. In general, there was a poor response to treatment with a disease-free interval of 3.4 and median survival time of 19 months in PSPS compared to 11.7 and 31 months in the PSOC patients. Patients with PSPS have more limited cytoreduction, shorter disease-free interval, and shorter overall survival time. Such differences prompt re-evaluation of treatment modalities for PSPS and recognition that this is a condition distinct from PSOC.

Entities:  

Mesh:

Year:  1993        PMID: 8276289     DOI: 10.1006/gyno.1993.1267

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  Tumorgrafts as in vivo surrogates for women with ovarian cancer.

Authors:  S John Weroha; Marc A Becker; Sergio Enderica-Gonzalez; Sean C Harrington; Ann L Oberg; Matthew J Maurer; Sarah E Perkins; Mariam AlHilli; Kristina A Butler; Sarah McKinstry; Stephanie Fink; Robert B Jenkins; Xiaonan Hou; Kimberly R Kalli; Karin M Goodman; Jann N Sarkaria; Beth Y Karlan; Amanika Kumar; Scott H Kaufmann; Lynn C Hartmann; Paul Haluska
Journal:  Clin Cancer Res       Date:  2014-01-07       Impact factor: 12.531

2.  Rare form of extraovarian primary peritoneal papillary serous carcinoma with solitary cystic lesion mimicking a liver tumor; report of a case.

Authors:  Yuji Iimuro; Koichiro Ohashi; Kazuhiro Suzumura; Seikan Hai; Shogo Tanaka; Ikuo Nakamura; Yuichi Kondo; Yasukane Asano; Toshihiro Okada; Tadamichi Hirano; Nobukazu Kuroda; Seiichi Hirota; Jiro Fujimoto
Journal:  Clin J Gastroenterol       Date:  2013-01-31

Review 3.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  Papillary serous carcinoma of peritoneum: presentation of 2 cases.

Authors:  Jaime Ruiz-Tovar; Joaquí Pérez de Oteyza; Roberto Rojo; Marta Vincenta Collado; Augusto García Villanueva
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

5.  Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses.

Authors:  Chao Zhang; Xiao-ping Li; Heng Cui; Dan-hua Shen; Li-hui Wei
Journal:  J Zhejiang Univ Sci B       Date:  2008-06       Impact factor: 3.066

Review 6.  [Surgical options in cancer of unknown primary (CUP)].

Authors:  T Schmidt; A Ulrich
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

7.  Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

8.  Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.

Authors:  John Farley; William E Brady; Vinod Vathipadiekal; Heather A Lankes; Robert Coleman; Mark A Morgan; Robert Mannel; S Diane Yamada; David Mutch; William H Rodgers; Michael Birrer; David M Gershenson
Journal:  Lancet Oncol       Date:  2012-12-21       Impact factor: 41.316

9.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

10.  Primary peritoneal adenocarcinoma causes pleural effusion.

Authors:  Mohammad Shameem; Jamal Akhtar; Ummul Baneen; Rakesh Bhargava; Zuber Ahmed; Prakhar Sharma; Nafees Ahmad Khan; Mohd Jaseem Hassan
Journal:  N Am J Med Sci       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.